Dr. Anthony L. Rostain, MD

Dr. Rostain practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Rostain's NPI, 1760418446, was assigned on June 24, 2006. Dr. Rostain graduated from New York University School of Medicine in 1980. Dr. Rostain holds New Jersey license 25MA10769500.

Dr. Rostain's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Dr. Rostain's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Rostain to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rostain practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Rostain's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Rostain's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 63 Medicare services from Dr. Rostain across 1 procedure code in 2024, all of them office visits, for 20 Medicare patients. Medicare paid $6,658 for them. Every service was in an office.

CMS counts 20 Medicare patients who saw Dr. Rostain in 2024. 75% of them have anxiety, and 65% have adhd and conduct disorders. Their average risk score is 0.63, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rostain's median patient age at 41, with 30% women.

In 2024, Dr. Rostain wrote 632 Medicare Part D claims for 31 patients. 89% of them were for generic drugs. CMS names the drug for 485 of them, across 26 drugs with 11 or more claims each, at $40,869 in total drug cost. In 2023, CMS named 454 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Rostain for performance year 2024, reported as part of a group. Dr. Rostain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rostain as offering telehealth.

Dmand AI links 27 papers to Dr. Rostain, published from 2012 to 2024. 2018 was the busiest year, with 4. The most frequent topics are Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants and Methylphenidate. Dr. Rostain has published most often in J Atten Disord. Dr. Rostain's most frequent co-authors are Jeffrey Harold Newcorn, MD, Eugene Victor Beresin, MD and Daniel F. Connor, MD.

Dmand AI links Dr. Rostain to 1 clinical trial. Conditions studied include Attention Deficit Disorder with Hyperactivity and Attention Deficit and Disruptive Behavior Disorders.

CMS Open Payments shows 153 general payments to Dr. Rostain from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Shire North American Group Inc paid the most, $113,315.

Dr. Rostain graduated from New York University School of Medicine in 1980.